Artelo Biosciences Inc. (ARTLW)
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 8:00 PM
0.01
0.00%
After-hours: Jun 17, 2024, 03:50 PM EDT
78.57% (1D)
| Bid | n/a |
| Market Cap | 13.07K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.29M |
| EPS (ttm) | -1.429 |
| PE Ratio (ttm) | -0.003918824352694192 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 29,400 |
| Avg. Volume (20D) | 0 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | 1.25 |
About ARTLW
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory b...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 21, 2019
Employees 5
Stock Exchange NASDAQ
Ticker Symbol ARTLW
Website https://www.artelobio.com